Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new therapies and detection of early lung disease
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Ratjen, H. Sheridan, P.S. Lee, T. Song, A. Stone, J. Davies (Toronto, Canada; London, United Kingdom; Cambridge, United States Of America). Effect of ivacaftor on lung clearance index and FEV₁ in subjects with CF who have the G551D-CFTR mutation and mild lung disease. Eur Respir J 2012; 40: Suppl. 56, 1841

Member's Comments

No comment yet.

Related content which might interest you: Is lung clearance index a better marker of abnormal airway function than FEV1 in children with asthma? Source: Annual Congress 2010 - Phenotypes, mechanisms and diagnosis of asthma in childhood Year: 2010 Impact of sensitization to Aspergillus fumigatus on lung function in cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more Year: 2010 Effect of posture on lung clearance index (LCI) and lung volumes in children with early stage cystic fibrosis lung disease Source: International Congress 2015 – Lung function: effects on method, machine and disease on the measurement Year: 2015 The impact of Achromobacter xylosoxidans on lung function and hospital admissions in adult patients with cystic fibrosis (CF) Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009 The effect of MRP1 variants and the intensity of MRP1 protein expression in bronchial biopsies on lung function decline in COPD Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD Year: 2010 Effect of ELTGOL on removal of lung secretion in patients with COPD Source: Annual Congress 2007 - Critical care and airways clearance Year: 2007 The effect of pirfenidone on impaired lung function in patients with idiopathic pulmonary fibrosis (IPF) from Czech IPF registry Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 The chance of developing lung cancers are more in combined pulmonary fibrosis & emphysema than emphysema alone Source: Annual Congress 2010 - Different patterns of interstitial lung disease Year: 2010 Impact of a single chronic obstructive pulmonary disease (COPD) exacerbation on lung function decline: Analysis of UPLIFT® Source: Annual Congress 2012 - Exacerbations of asthma and COPD: assessment, impact and novel treatments Year: 2012 Effect of baseline FVC on lung function decline with nintedanib in patients with IPF Source: International Congress 2015 – Treatment of IPF Year: 2015 Pulmonary function response in smokers and patients with chronic obstructive lung disease (COPD) following exposure to concentrated fine (PM2.5) particles Source: Annual Congress 2009 - Indoor and outdoor air pollution Year: 2009 Pi3kδ expression is increased in peripheral lung macrophages in COPD patients Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009 Study of a lung volume reduction coilÔ for the treatment of emphysema Source: Annual Congress 2009 - Treatment beyond inhalers Year: 2009 Long-term course of lung clearance index among patients with cystic fibrosis Source: Virtual Congress 2020 – Respiratory physiology and sleep: new approaches to diagnosis and treatment Year: 2020 Lung clearance index in adult cystic fibrosis patients: the role of convection-dependent lung units Source: Eur Respir J 2013; 42: 380-388 Year: 2013 Benefit of treatment with pirfenidone (PFD) persists over time in patients with idiopathic pulmonary fibrosis (IPF) with limited lung function impairment Source: International Congress 2016 – IPF treatment I Year: 2016 The "rapid decliner" COPD phenotype Source: Annual Congress 2010 - COPD: diagnosis Year: 2010 Impact of bisphosphonate (BP) use on lung function decline and treatment response in patients (pts) with idiopathic pulmonary fibrosis (IPF) Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis Year: 2020 Effect of recurrent growth of aspergillus on lung function in paediatric population with cystic fibrosis (CF) Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge Year: 2011 COPD prevalence in lung cancer patients – Is COPD a risk factor for lung cancer? Source: Annual Congress 2011 - Epidemiology of lung cancer and screening Year: 2011